327 related articles for article (PubMed ID: 32929365)
21. Synthesis and structure-activity relationships for 2,4-dinitrobenzamide-5-mustards as prodrugs for the Escherichia coli nfsB nitroreductase in gene therapy.
Atwell GJ; Yang S; Pruijn FB; Pullen SM; Hogg A; Patterson AV; Wilson WR; Denny WA
J Med Chem; 2007 Mar; 50(6):1197-212. PubMed ID: 17326614
[TBL] [Abstract][Full Text] [Related]
22. Discovery and evaluation of Escherichia coli nitroreductases that activate the anti-cancer prodrug CB1954.
Prosser GA; Copp JN; Syddall SP; Williams EM; Smaill JB; Wilson WR; Patterson AV; Ackerley DF
Biochem Pharmacol; 2010 Mar; 79(5):678-87. PubMed ID: 19852945
[TBL] [Abstract][Full Text] [Related]
23. The Flavin Reductase MsuE Is a Novel Nitroreductase that Can Efficiently Activate Two Promising Next-Generation Prodrugs for Gene-Directed Enzyme Prodrug Therapy.
Green LK; Storey MA; Williams EM; Patterson AV; Smaill JB; Copp JN; Ackerley DF
Cancers (Basel); 2013 Aug; 5(3):985-97. PubMed ID: 24202330
[TBL] [Abstract][Full Text] [Related]
24. Adenovirus-mediated hypoxia-targeted gene therapy using HSV thymidine kinase and bacterial nitroreductase prodrug-activating genes in vitro and in vivo.
Harvey TJ; Hennig IM; Shnyder SD; Cooper PA; Ingram N; Hall GD; Selby PJ; Chester JD
Cancer Gene Ther; 2011 Nov; 18(11):773-84. PubMed ID: 21836632
[TBL] [Abstract][Full Text] [Related]
25. The 2-nitroimidazole EF5 is a biomarker for oxidoreductases that activate the bioreductive prodrug CEN-209 under hypoxia.
Wang J; Foehrenbacher A; Su J; Patel R; Hay MP; Hicks KO; Wilson WR
Clin Cancer Res; 2012 Mar; 18(6):1684-95. PubMed ID: 22167409
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and evaluation of nitroheterocyclic carbamate prodrugs for use with nitroreductase-mediated gene-directed enzyme prodrug therapy.
Hay MP; Anderson RF; Ferry DM; Wilson WR; Denny WA
J Med Chem; 2003 Dec; 46(25):5533-45. PubMed ID: 14640560
[TBL] [Abstract][Full Text] [Related]
27. Oxygen-insensitive nitroreductase E. coli NfsA, but not NfsB, is inhibited by fumarate.
Day MA; Jarrom D; Rajah N; Searle PF; Hyde EI; White SA
Proteins; 2023 May; 91(5):585-592. PubMed ID: 36443029
[TBL] [Abstract][Full Text] [Related]
28. Intracellular complexities of acquiring a new enzymatic function revealed by mass-randomisation of active-site residues.
Hall KR; Robins KJ; Williams EM; Rich MH; Calcott MJ; Copp JN; Little RF; Schwörer R; Evans GB; Patrick WM; Ackerley DF
Elife; 2020 Nov; 9():. PubMed ID: 33185191
[TBL] [Abstract][Full Text] [Related]
29. Non-invasive PET and SPECT imaging of tissue hypoxia using isotopically labeled 2-nitroimidazoles.
Koch CJ; Evans SM
Adv Exp Med Biol; 2003; 510():285-92. PubMed ID: 12580442
[TBL] [Abstract][Full Text] [Related]
30. Nitroreductase, a near-infrared reporter platform for in vivo time-domain optical imaging of metastatic cancer.
McCormack E; Silden E; West RM; Pavlin T; Micklem DR; Lorens JB; Haug BE; Cooper ME; Gjertsen BT
Cancer Res; 2013 Feb; 73(4):1276-86. PubMed ID: 23233739
[TBL] [Abstract][Full Text] [Related]
31. Cellular pharmacology of evofosfamide (TH-302): A critical re-evaluation of its bystander effects.
Hong CR; Dickson BD; Jaiswal JK; Pruijn FB; Hunter FW; Hay MP; Hicks KO; Wilson WR
Biochem Pharmacol; 2018 Oct; 156():265-280. PubMed ID: 30134191
[TBL] [Abstract][Full Text] [Related]
32. Reduction of quinones and nitroaromatic compounds by Escherichia coli nitroreductase A (NfsA): Characterization of kinetics and substrate specificity.
Valiauga B; Williams EM; Ackerley DF; Čėnas N
Arch Biochem Biophys; 2017 Jan; 614():14-22. PubMed ID: 27986535
[TBL] [Abstract][Full Text] [Related]
33. Spatially-resolved pharmacokinetic/pharmacodynamic modelling of bystander effects of a nitrochloromethylbenzindoline hypoxia-activated prodrug.
Hong CR; Mehta SY; Liyanage HDS; McManaway SP; Lee HH; Jaiswal JK; Bogle G; Tercel M; Pruijn FB; Wilson WR; Hicks KO
Cancer Chemother Pharmacol; 2021 Oct; 88(4):673-687. PubMed ID: 34245333
[TBL] [Abstract][Full Text] [Related]
34. Biochemical characterization of trinitrotoluene transforming oxygen-insensitive nitroreductases from Clostridium acetobutylicum ATCC 824.
Kutty R; Bennett GN
Arch Microbiol; 2005 Nov; 184(3):158-67. PubMed ID: 16187099
[TBL] [Abstract][Full Text] [Related]
35. Biodistribution and dosimetry of (18)F-EF5 in cancer patients with preliminary comparison of (18)F-EF5 uptake versus EF5 binding in human glioblastoma.
Koch CJ; Scheuermann JS; Divgi C; Judy KD; Kachur AV; Freifelder R; Reddin JS; Karp J; Stubbs JB; Hahn SM; Driesbaugh J; Smith D; Prendergast S; Evans SM
Eur J Nucl Med Mol Imaging; 2010 Nov; 37(11):2048-59. PubMed ID: 20585774
[TBL] [Abstract][Full Text] [Related]
36. Characteristics of major Escherichia coli reductases involved in aerobic nitro and azo reduction.
Mercier C; Chalansonnet V; Orenga S; Gilbert C
J Appl Microbiol; 2013 Oct; 115(4):1012-22. PubMed ID: 23795903
[TBL] [Abstract][Full Text] [Related]
37. Residue Phe42 is critical for the catalytic activity of Escherichia coli major nitroreductase NfsA.
Yang J; Zhan J; Bai J; Liu P; Xue Y; Yang Q
Biotechnol Lett; 2013 Oct; 35(10):1693-700. PubMed ID: 23801116
[TBL] [Abstract][Full Text] [Related]
38. Optimized clostridium-directed enzyme prodrug therapy improves the antitumor activity of the novel DNA cross-linking agent PR-104.
Liu SC; Ahn GO; Kioi M; Dorie MJ; Patterson AV; Brown JM
Cancer Res; 2008 Oct; 68(19):7995-8003. PubMed ID: 18829557
[TBL] [Abstract][Full Text] [Related]
39. Sensitization of colorectal and pancreatic cancer cell lines to the prodrug 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954) by retroviral transduction and expression of the E. coli nitroreductase gene.
Green NK; Youngs DJ; Neoptolemos JP; Friedlos F; Knox RJ; Springer CJ; Anlezark GM; Michael NP; Melton RG; Ford MJ; Young LS; Kerr DJ; Searle PF
Cancer Gene Ther; 1997; 4(4):229-38. PubMed ID: 9253508
[TBL] [Abstract][Full Text] [Related]
40. Imaging of tumor hypoxia to predict treatment sensitivity.
Minn H; Grönroos TJ; Komar G; Eskola O; Lehtiö K; Tuomela J; Seppänen M; Solin O
Curr Pharm Des; 2008; 14(28):2932-42. PubMed ID: 18991711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
